GA96HB332 96 HB 332 PRESCRIPTION DRUG ETHICAL ACT Creates the Prescription Drug Ethical Marketing Act. Requires every manufacturer and labeler that sells prescription drugs in the State to disclose to the Director of Public Health the value, nature, and purpose of any gift, fee, payment, subsidy, or other economic benefit provided in connection with detailing or promotional or other marketing activities by the company, directly or through its pharmaceutical marketers, to any physician, hospital, nursing home, pharmacist, health benefit plan administrator, or any other person in the State authorized to prescribe or dispense prescription drugs. Requires the Director to report to the Governor and the General Assembly on the disclosures. Provides exceptions to the disclosures. Provides for injunctive relief and civil penalties for failure to disclose. Amends the State Finance Act to create the Prescription Drug Ethical Marketing Fund. http://www.ilga.gov/legislation/BillStatus.asp?DocNum=332&GAID=10&DocTypeID=HB&LegId=40512&SessionID=76&GA=96 2010-03-15 00:00:00 House Rule 19(a) / Re-referred to Rules Committee 1 8 HRUL 2010-02-19 00:00:00 House Added Co-Sponsor Rep. Deborah Mell 0 7 2010-01-27 00:00:00 House Assigned to Human Services Committee 0 6 HHSV 2009-03-13 00:00:00 House Rule 19(a) / Re-referred to Rules Committee 0 5 HRUL 2009-01-27 00:00:00 House First Reading 1 1 2009-02-04 00:00:00 House Assigned to Human Services Committee 0 3 HHSV 2009-02-06 00:00:00 House Added Co-Sponsor Rep. Fred Crespo 0 4 2009-01-27 00:00:00 House Referred to Rules Committee 0 2 HRUL 2009-01-23 00:00:00 House Filed with the Clerk by Rep. Jack D. Franks 0 0 2010-03-26 00:00:00 House Added Co-Sponsor Rep. Eddie Washington 0 9 DeborahMell House Co-Sponsor FredCrespo House Co-Sponsor JackDFranks House Chief Sponsor EddieWashington House Co-Sponsor